628 antibodies registered
| Antibody ID ∧ ∨ | Antibody name ∧ ∨ | Epitope ID ∧ ∨ | Epitope name ∧ ∨ | Recognition region ∧ ∨ |
|---|---|---|---|---|
| AN0138 | MO-225 | EP0084 | Chindroitin Sulfate D Unit | -{[HSO3(-2)]GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
| AN0456 | JM13 / JM-13 | EP0086 | Heparan Sulfate | -{[HSO3(-2)]GlcA(b1-4)GlcNSO3(a1-4)}n- (GlcA2S-GlcNS) -{[HSO3(-2)]GlcA(b1-4)GlcN(a1-4)}n- (GlcA2S-GlcN) |
| AN0331 | MW3G3 | EP0086 | Heparan Sulfate | -{[HSO3(-2)]IdoA(a1-4)GlcNAc(a1-4)}n- (IdoA2S-GlcNAc) |
| AN0331 | MW3G3 | EP0088 | Acharan Sulfate | -{[HSO3(-2)]IdoA(a1-4)GlcNAc(a1-4)}n- (IdoA2S-GlcNAc) |
| AN0454 | AO4B08 | EP0086 | Heparan Sulfate | -{[HSO3(-6)]GlcNSO3(a1-4)[HSO3(-2)]IdoA(a1-4)[HSO3(-6)]GlcNSO3(a1-4)}- (GlcNS6S-IdoA2S-GlcNS6S) |
| AN0332 | HS4C3 | EP0086 | Heparan Sulfate | -{[HSO3(-6)]GlcNSO3(a1-4)[HSO3(-2)]IdoA(a1-4)}- (GlcNS6S-IdoA2S) -{[HSO3(-6)][HSO3(-3)]GlcNSO3(a1-4)[HSO3(-2)]IdoA(a1-4)}- (GlcNS6S3S-IdoA2S) 3-O-sulfated HS stractures |
| AN0804 | LM17 | EP0508 | Arabinan | Arabinan |
| AN0810 | LM9 | EP0506 | beta 1-4 Galactan | Feruloylated beta 1-4 Galactan |
| AN0245 | B389 | EP0250 | Blood Group H Disaccharide | Fuc(a1-2)Gal(b1-)-R |
| AN0768 | RGM31 | EP0250 | Blood Group H Disaccharide | Fuc(a1-2)Gal(b1-)-R |
| AN0352 | CCRC-M1 | EP0511 | Xyloglucan | Fuc(a1-2)Gal(b1-)-R |
| AN0221 | 1E3 | EP0250 | Blood Group H Disaccharide | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0222 | 3H1 | EP0250 | Blood Group H Disaccharide | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0221 | 1E3 | EP0251 | Blood Group H Type 1 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0222 | 3H1 | EP0251 | Blood Group H Type 1 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0221 | 1E3 | EP0252 | Blood Group H Type 2 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0222 | 3H1 | EP0252 | Blood Group H Type 2 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0221 | 1E3 | EP0253 | Blood Group H Type 3 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0222 | 3H1 | EP0253 | Blood Group H Type 3 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0221 | 1E3 | EP0254 | Blood Group H Type 4 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0222 | 3H1 | EP0254 | Blood Group H Type 4 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0478 | MBr1 | EP0253 | Blood Group H Type 3 | Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0478 | MBr1 | EP0254 | Blood Group H Type 4 | Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
| AN0718 | anti-fucosyl asialo GM1 IgG | EP0057 | Fucosyl Asialo-GM1 | Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer |
| AN0715 | anti-fucosyl GM1 | EP0049 | Fucosyl GM1 | Fuc(a1-2)Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |